GPT and neoplasm: This combination regimen exerted synergistic suppression on tumor numbers, liver-to-body weight ratios, serum ALT and AST levels as compared to sorafenib or pifithrin-μ alone (Figs. 7D–G and S7D–E), without significant impact on body weights of mice (Fig. S7C).